PATENT CLAIM ANALYSIS

Application Number: 16054728
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["544", "343000"]

Abstract:
This invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT 2A  receptor, serotonin transporter (SERT) and/or pathways involving dopamine D 1 /D 2  receptor signaling systems, and/or the treatment of residual symptoms.

Claim (Index 12):
A method for the treatment or prophylaxis of a central nervous system disorder comprising administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition according to  claim 11 .

Metadata:
- Claim Count in Document: 53.0
- Percentile: 96.0
- Lexical Diversity: 1.29091
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15301895', '16088397', '15301912', '14394467', '15629481']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915532286845215
- 35 USC 102 Novelty (BERT): 0.5465077118799079
- Combined Prediction Score: 0.7670486770040601
- Mean Citation Score: 377.4376160000001
- Max Citation Score: 431.4497
- Similarity Product: 315.634219247365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test